Monica S Webb1. 1. Department of Psychology, Syracuse University, Syracuse, NY 13244-2340, USA. mswebb@syr.edu
Abstract
OBJECTIVE: African Americans suffer disproportionately from smoking-related morbidity and mortality; yet it is unclear whether existing treatments benefit this population. The purposes of this meta-analysis were to evaluate the overall efficacy of smoking cessation interventions (SCIs) among African American adults and to examine specific study characteristics and methods that influence treatment outcome. DESIGN: Twenty published and unpublished studies representing 32 hypothesis tests and 12,743 smokers compared SCIs to control conditions. MAIN OUTCOME MEASURES: (1) Smoking abstinence post-treatment; (2) abstinence at the first follow-up assessment; and (3) 11 potential moderators of treatment effects. RESULTS: Overall, SCIs increased the odds of cessation by 40% at posttest and 30% at follow-up. Treatment type, setting, cultural specificity, unit of analysis, outcome measure, nature of control group, and biochemical verification moderated the overall treatment effect size. CONCLUSION: SCIs are efficacious among African Americans. Theoretical, clinical, and future research implications are discussed.
OBJECTIVE: African Americans suffer disproportionately from smoking-related morbidity and mortality; yet it is unclear whether existing treatments benefit this population. The purposes of this meta-analysis were to evaluate the overall efficacy of smoking cessation interventions (SCIs) among African American adults and to examine specific study characteristics and methods that influence treatment outcome. DESIGN: Twenty published and unpublished studies representing 32 hypothesis tests and 12,743 smokers compared SCIs to control conditions. MAIN OUTCOME MEASURES: (1) Smoking abstinence post-treatment; (2) abstinence at the first follow-up assessment; and (3) 11 potential moderators of treatment effects. RESULTS: Overall, SCIs increased the odds of cessation by 40% at posttest and 30% at follow-up. Treatment type, setting, cultural specificity, unit of analysis, outcome measure, nature of control group, and biochemical verification moderated the overall treatment effect size. CONCLUSION: SCIs are efficacious among African Americans. Theoretical, clinical, and future research implications are discussed.
Authors: Taneisha S Buchanan; Carla J Berg; Lisa Sanderson Cox; Niaman Nazir; Neal L Benowitz; Lisa Yu; Olivia Yturralde; Peyton Jacob; Won S Choi; Jasjit S Ahluwalia; Nicole L Nollen Journal: Nicotine Tob Res Date: 2012-02-24 Impact factor: 4.244
Authors: Monica Webb Hooper; Taghrid Asfar; Marina Unrod; Asha Dorsey; John B Correa; Karen O Brandon; Vani N Simmons; Michael A Antoni; Tulay Koru-Sengul; David J Lee; Thomas H Brandon Journal: Ethn Dis Date: 2019-01-17 Impact factor: 1.847
Authors: Vani Nath Simmons; Barbara Pineiro; Monica Webb Hooper; Jhanelle E Gray; Thomas H Brandon Journal: Cancer Control Date: 2016-10 Impact factor: 3.302
Authors: Babalola Faseru; Nicole L Nollen; Matthew S Mayo; Ron Krebill; Won S Choi; Neal L Benowitz; Rachel F Tyndale; Kolawole S Okuyemi; Jasjit S Ahluwalia; Lisa Sanderson Cox Journal: Addict Behav Date: 2012-11-29 Impact factor: 3.913
Authors: Peter S Hendricks; J Lee Westmaas; Van M Ta Park; Christopher B Thorne; Sabrina B Wood; Majel R Baker; R Marsh Lawler; Monica Webb Hooper; Kevin L Delucchi; Sharon M Hall Journal: Psychol Addict Behav Date: 2013-03-25
Authors: Margaret E Ensminger; Katherine Clegg Smith; Hee-Soon Juon; Jennifer L Pearson; Judith A Robertson Journal: Drug Alcohol Depend Date: 2009-07-17 Impact factor: 4.492
Authors: Pragati S Advani; Lorraine R Reitzel; Nga T Nguyen; Felicia D Fisher; Elaine J Savoy; Adolfo G Cuevas; David W Wetter; Lorna H McNeill Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-04-16 Impact factor: 4.254